New pill shows promise for Hard-to-Treat blood cancers
Disease control
Ongoing
This study tests an experimental oral drug, cemsidomide (CFT7455), in adults with non-Hodgkin's lymphoma or multiple myeloma that has returned or stopped responding to treatment. The main goals are to check the drug's safety and find the best dose, while also seeing if it can shr…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC